A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented at the American Society for Radiation Oncology’s (ASTRO) 55th Annual Meeting. The study confirmed a disease-specific-survival (DSS) rate of 95 percent when patients received fewer weeks of neoadjuvant (NEO) total androgen suppression (TAS).
GE Healthcare Silent Scan MRI Systems Noiseless Spectrum Health Michigan

GE Healthcare reported that Silent Scan, a revolutionary technology that dramatically quiets magnetic resonance imaging (MRI) exams, is now commercially available and growing in clinical adoption around the world. Silent Scan addresses one of the most significant impediments to patient comfort — excessive acoustic noise generated during an MRI scan. Conventional MRI scanners can generate noise in excess of 110 decibels, roughly equivalent to rock concerts and requiring ear protection. GE’s exclusive Silent Scan technology is designed to reduce MR scanner noise to ambient (background) sound levels and improve a patient’s MRI exam experience.
ASTRO 2013 Clinical Study Limited Brain Metastases Stereotactic Radiosurgey

When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT.

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.

Varian Medical Systems and Siemens Healthcare showcased a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO).

Nucletron, an Elekta company has launched Esteya, a new approach for treating patients with skin cancer.

Elekta has introduced Monaco 5.0, which consolidates support for clinically useful delivery techniques in a single treatment planning system, and features refinements to planning speed and precision.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now